Viewray Newsroom

Stifel Nicolaus Keeps Their Hold Rating on Viewray (VRAY)

TipRanksJun 7, 2023 10:17

Analysts Conflicted on These Healthcare Names: Pliant Therapeutics (PLRX), Krystal Biotech (KRYS) and Viewray (VRAY)

TipRanksMay 30, 2023 10:10

Viewray (VRAY) Receives a Hold From Stifel Nicolaus

TipRanksMay 25, 2023 10:08

Morgan Stanley Maintains Equal-Weight on ViewRay, Lowers Price Target to $1

BenzingaMay 11, 2023 20:33

BTIG Remains a Hold on Viewray (VRAY)

TipRanksMay 11, 2023 09:45

Piper Sandler Maintains Overweight on ViewRay, Lowers Price Target to $2

BenzingaApr 24, 2023 22:10

Jefferies Downgrades ViewRay to Hold, Lowers Price Target to $1.25

BenzingaApr 17, 2023 17:40

Jefferies Downgrades Viewray (VRAY) to a Hold

TipRanksApr 17, 2023 17:06

Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Tonix Pharma (TNXP) and Viewray (VRAY)

TipRanksApr 14, 2023 20:36

Morgan Stanley Maintains Equal-Weight on ViewRay, Lowers Price Target to $2

BenzingaApr 14, 2023 20:10

B. Riley Lowers ViewRay's Price Target to $4 From $8 After Softer-Than-Expected Q1 Revenue, Keeps Buy Rating

MT NewswiresApr 14, 2023 19:39

Stifel Downgrades ViewRay to Hold, Lowers Price Target to $1.75

BenzingaApr 14, 2023 17:35

Stifel Nicolaus Downgrades Viewray (VRAY) to a Hold

TipRanksApr 14, 2023 16:16

B.Riley Financial Keeps Their Buy Rating on Viewray (VRAY)

TipRanksApr 14, 2023 09:37

BTIG Gives a Buy Rating to Viewray (VRAY)

TipRanksApr 13, 2023 21:47

Oppenheimer Keeps Their Buy Rating on Viewray (VRAY)

TipRanksMar 1, 2023 00:31

Oppenheimer Reiterates Outperform on ViewRay, Maintains $8 Price Target

BenzingaFeb 28, 2023 21:00

Morgan Stanley Sticks to Its Hold Rating for Viewray (VRAY)

TipRanksFeb 28, 2023 20:21

BTIG Sticks to Its Buy Rating for Viewray (VRAY)

TipRanksFeb 28, 2023 13:15

Analysts Offer Insights on Healthcare Companies: Viewray (VRAY) and IN8bio (INAB)

TipRanksJan 5, 2023 22:00